Cite
HARVARD Citation
Torregrosa, C. et al. (2022). FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study. International journal of cancer. 151 (11), pp. 1978-1988. [Online].